• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.嗅觉功能障碍作为帕金森病的早期生物标志物。
Neurosci Bull. 2017 Oct;33(5):515-525. doi: 10.1007/s12264-017-0170-x. Epub 2017 Aug 22.
2
Olfaction as an early marker of Parkinson's disease and Alzheimer's disease.嗅觉障碍作为帕金森病和阿尔茨海默病的早期标志物。
Handb Clin Neurol. 2021;182:317-329. doi: 10.1016/B978-0-12-819973-2.00030-7.
3
Association between olfactory loss and cognitive deficits in Parkinson's disease.帕金森病嗅觉丧失与认知缺陷之间的关联。
Clin Neurol Neurosurg. 2018 Oct;173:120-123. doi: 10.1016/j.clineuro.2018.08.018. Epub 2018 Aug 13.
4
Anosmia and Ageusia in Parkinson's Disease.帕金森病中的嗅觉丧失和味觉丧失
Int Rev Neurobiol. 2017;133:541-556. doi: 10.1016/bs.irn.2017.05.028. Epub 2017 Jun 27.
5
Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.帕金森病患者嗅觉功能、运动症状、认知障碍、淡漠和疲劳之间的相关性。
J Neurol. 2018 Aug;265(8):1764-1771. doi: 10.1007/s00415-018-8913-9. Epub 2018 May 26.
6
Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.帕金森病患者嗅觉减退与认知障碍的气味选择性
Clin Interv Aging. 2017 Oct 9;12:1637-1644. doi: 10.2147/CIA.S147588. eCollection 2017.
7
Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction.帕金森病的嗅觉和味觉:与轻度认知障碍和单一认知领域功能障碍的关联。
J Neural Transm (Vienna). 2019 May;126(5):585-595. doi: 10.1007/s00702-019-01996-z. Epub 2019 Mar 25.
8
Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.药物未治疗的帕金森病伴轻度认知障碍患者的嗅觉功能障碍。
Parkinsonism Relat Disord. 2018 Jan;46:69-73. doi: 10.1016/j.parkreldis.2017.11.334. Epub 2017 Nov 14.
9
Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease.嗅觉失认症是帕金森病认知衰退和痴呆转化的预测指标。
J Neurol. 2019 Jul;266(7):1601-1610. doi: 10.1007/s00415-019-09297-x. Epub 2019 Apr 22.
10
[Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis].[帕金森病中的嗅觉功能障碍:其在早期及鉴别诊断中作为一项新主要体征的作用]
Nervenarzt. 2008 Feb;79(2):175-84. doi: 10.1007/s00115-007-2326-9.

引用本文的文献

1
Olfactory dysfunction and amyloid-positivity in Parkinson's disease-longitudinal analysis of cognitive decline and cerebrospinal fluid markers.帕金森病中的嗅觉功能障碍与淀粉样蛋白阳性——认知衰退和脑脊液标志物的纵向分析
PLoS One. 2025 Aug 21;20(8):e0325560. doi: 10.1371/journal.pone.0325560. eCollection 2025.
2
Olfactory network reorganization in Parkinson's disease.帕金森病中的嗅觉网络重组
Parkinsonism Relat Disord. 2025 Sep;138:107964. doi: 10.1016/j.parkreldis.2025.107964. Epub 2025 Jul 29.
3
Fasting and postprandial Ghrelin levels in Parkinson's disease: a systematic review and meta-analysis.帕金森病患者的空腹及餐后胃饥饿素水平:一项系统评价与荟萃分析
NPJ Parkinsons Dis. 2025 Jul 14;11(1):212. doi: 10.1038/s41531-025-01066-0.
4
Self-testing for symptoms and signs of prodromal alpha-synucleinopathies: results from the Tasmanian ISLAND Sleep Study.前驱性α-突触核蛋白病症状和体征的自我检测:塔斯马尼亚岛睡眠研究结果
Geroscience. 2025 Jul 1. doi: 10.1007/s11357-025-01757-9.
5
Unsupervised subtyping of motor dysfunction of Parkinson's disease and its structural brain imaging correlates.帕金森病运动功能障碍的无监督亚型分类及其脑结构成像相关性。
Neuroimage Rep. 2025 Mar 1;5(1):100246. doi: 10.1016/j.ynirp.2025.100246. eCollection 2025 Mar.
6
Novel Gene-Informed Regional Brain Targets for Clinical Screening for Major Depression.用于重度抑郁症临床筛查的新型基因导向性脑区靶点
Neurol Int. 2025 Jun 19;17(6):96. doi: 10.3390/neurolint17060096.
7
Olfactory Dysfunction in a Novel Model of Prodromal Parkinson's Disease in Adult Zebrafish.成年斑马鱼前驱期帕金森病新模型中的嗅觉功能障碍
Int J Mol Sci. 2025 May 8;26(10):4474. doi: 10.3390/ijms26104474.
8
Redefining Non-Motor Symptoms in Parkinson's Disease.重新定义帕金森病的非运动症状
J Pers Med. 2025 Apr 26;15(5):172. doi: 10.3390/jpm15050172.
9
Alpha-synuclein pathology and Parkinson's disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches.α-突触核蛋白病理学与帕金森病相关嗅觉功能障碍:临床前模型与治疗方法的最新进展
Mamm Genome. 2025 Apr 28. doi: 10.1007/s00335-025-10128-w.
10
Neuroprotective Activities of Sertraline, Tiagabine, and Bicifadine with Autophagy-Inducing Potentials in a 6-Hydroxidopamine-Treated Parkinson's Disease Cell Model.舍曲林、噻加宾和比西法定在6-羟基多巴胺处理的帕金森病细胞模型中的神经保护活性及自噬诱导潜力
Neurochem Res. 2025 Apr 25;50(3):154. doi: 10.1007/s11064-025-04404-z.

本文引用的文献

1
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.嗅觉障碍预示着疑似药物性帕金森综合征潜在的多巴胺能缺陷。
Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.
2
Olfactory dysfunction and its measurement in the clinic.嗅觉功能障碍及其在临床中的测量。
World J Otorhinolaryngol Head Neck Surg. 2015 Oct 26;1(1):28-33. doi: 10.1016/j.wjorl.2015.09.007. eCollection 2015 Sep.
3
Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate?神经退行性疾病中的嗅觉功能障碍:是否存在共同的病理基础?
Lancet Neurol. 2017 Jun;16(6):478-488. doi: 10.1016/S1474-4422(17)30123-0.
4
Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.新诊断帕金森病患者的嗅觉功能障碍与痴呆
Parkinsonism Relat Disord. 2017 May;38:41-47. doi: 10.1016/j.parkreldis.2017.02.017. Epub 2017 Feb 21.
5
Olfactory ability in normal pressure hydrocephalus as compared to Alzheimer's disease and healthy controls.与阿尔茨海默病和健康对照相比,正常压力脑积水患者的嗅觉能力。
J Neurol Sci. 2017 Jan 15;372:217-219. doi: 10.1016/j.jns.2016.11.049. Epub 2016 Nov 22.
6
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.临床变量和生物标志物在新诊断帕金森病患者认知障碍预测中的作用:一项队列研究
Lancet Neurol. 2017 Jan;16(1):66-75. doi: 10.1016/S1474-4422(16)30328-3. Epub 2016 Nov 18.
7
The Taste and Smell Protocol in the 2011-2014 US National Health and Nutrition Examination Survey (NHANES): Test-Retest Reliability and Validity Testing.2011 - 2014年美国国家健康与营养检查调查(NHANES)中的味觉和嗅觉检测方案:重测信度和效度测试
Chemosens Percept. 2015 Sep;8(3):138-148. doi: 10.1007/s12078-015-9194-7. Epub 2015 Aug 7.
8
The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.快速眼动睡眠行为障碍与嗅觉减退对帕金森病认知和运动表型的联合影响。
J Neurol Sci. 2016 Sep 15;368:374-8. doi: 10.1016/j.jns.2016.07.057. Epub 2016 Jul 26.
9
Associations of olfactory bulb and depth of olfactory sulcus with basal ganglia and hippocampus in patients with Parkinson's disease.帕金森病患者嗅球及嗅沟深度与基底神经节和海马的相关性
Neurosci Lett. 2016 May 4;620:111-4. doi: 10.1016/j.neulet.2016.03.050. Epub 2016 Mar 29.
10
Olfactory impairment predicts cognitive decline in early Parkinson's disease.嗅觉障碍预示早期帕金森病的认知衰退。
Parkinsonism Relat Disord. 2016 Apr;25:45-51. doi: 10.1016/j.parkreldis.2016.02.013. Epub 2016 Feb 19.

嗅觉功能障碍作为帕金森病的早期生物标志物。

Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

机构信息

Parkinson's Disease Research, Education and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, 19104, USA.

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104, USA.

出版信息

Neurosci Bull. 2017 Oct;33(5):515-525. doi: 10.1007/s12264-017-0170-x. Epub 2017 Aug 22.

DOI:10.1007/s12264-017-0170-x
PMID:28831680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5636737/
Abstract

Olfactory dysfunction is common in Parkinson's disease (PD) and often predates the diagnosis by years, reflecting early deposition of Lewy pathology, the histologic hallmark of PD, in the olfactory bulb. Clinical tests are available that allow for the rapid characterization of olfactory dysfunction, including tests of odor identification, discrimination, detection, and recognition thresholds, memory, and tests assessing the build-up of odor intensity across increasing suprathreshold stimulus concentrations. The high prevalence of olfactory impairment, along with the ease and low cost of assessment, has fostered great interest in olfaction as a potential biomarker for PD. Hyposmia may help differentiate PD from other causes of parkinsonism, and may also aid in the identification of "pre-motor" PD due to the early pathologic involvement of olfactory pathways. Olfactory function is also correlated with other non-motor features of PD and may serve as a predictor of cognitive decline. In this article, we summarize the existing literature on olfaction in PD, focusing on the potential for olfaction as a biomarker for early or differential diagnosis and prognosis.

摘要

嗅觉功能障碍在帕金森病(PD)中很常见,并且通常在诊断前数年就已经出现,这反映了Lewy 病理学(PD 的组织学标志)在嗅球中的早期沉积。现已有临床测试可用于快速描述嗅觉功能障碍,包括气味识别、辨别、检测和识别阈值、记忆测试,以及评估随着超阈值刺激浓度增加气味强度累积的测试。嗅觉损伤的高患病率,加上评估的简便性和低成本,使得嗅觉作为 PD 潜在生物标志物的可能性引起了极大的关注。嗅觉减退可能有助于将 PD 与其他帕金森病原因区分开来,并且由于嗅觉通路的早期病理参与,也可能有助于识别“运动前”PD。嗅觉功能也与 PD 的其他非运动特征相关,并且可能作为认知能力下降的预测指标。在本文中,我们总结了 PD 中嗅觉的现有文献,重点介绍了嗅觉作为早期或鉴别诊断和预后生物标志物的潜力。